Company Overview of Takeda GmbH
Takeda GmbH, through its subsidiaries, is engaged in the research and development, manufacture, and sales of patented products, branded generics, and over-the-counter products. It offers diabetes treatment pioglitazone hydrochloride tables that improve insulin sensitivity and reduces blood glucose levels; diabetes treatment alogliptin benzoate that lowers blood glucose levels; Candesartan cilexetil, an angiotensin II receptor blocker for hypertension treatment; Azilsartan, a angiotensin II receptor blocke; and omega-3-acid ethyl esters. The company provides products on various therapeutic areas that include cardiovascular and metabolic, oncology, central nervous system, respiratory and immun...
Founded in 1873
Key Executives for Takeda GmbH
Research & Development Head and Member of Management Board
Human Resources & Information Technology Head and Member of the Board of Management
Vice President of Clinical and Scientific Affairs
Finance & Operations Head and Member of The Board of Management
Compensation as of Fiscal Year 2014.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries